Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin + GemAOD in Untreated NK/T Cell Lymphoma
NCT01921790Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2013
- Primary completion
- Aug 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT)
Beyond the preview
Go deeper on NCT01921790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01921790.